These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24903374)

  • 1. A Review and Analysis of the YODA Trials: What Can We Glean Clinically?
    Le ME; Kurd MF
    Curr Rev Musculoskelet Med; 2014 Sep; 7(3):189-92. PubMed ID: 24903374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staff report on Medtronic's influence on INFUSE clinical studies.
    United States Senate Finance Committee
    Int J Occup Environ Health; 2013; 19(2):67-76. PubMed ID: 23684264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Straight talk with...Harlan Krumholz.
    Krumholz H; Khamsi R
    Nat Med; 2014 Mar; 20(3):225. PubMed ID: 24603783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview and experience of the YODA Project with clinical trial data sharing after 5 years.
    Ross JS; Waldstreicher J; Bamford S; Berlin JA; Childers K; Desai NR; Gamble G; Gross CP; Kuntz R; Lehman R; Lins P; Morris SA; Ritchie JD; Krumholz HM
    Sci Data; 2018 Nov; 5():180268. PubMed ID: 30480665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive assessment of the risk of bone morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis.
    Cahill KS; McCormick PC; Levi AD
    J Neurosurg Spine; 2015 Jul; 23(1):86-93. PubMed ID: 25860517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The controversy surrounding bone morphogenetic proteins in the spine: a review of current research.
    Hustedt JW; Blizzard DJ
    Yale J Biol Med; 2014 Dec; 87(4):549-61. PubMed ID: 25506287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Yale Open Data Access (YODA) Project--A Mechanism for Data Sharing.
    Krumholz HM; Waldstreicher J
    N Engl J Med; 2016 Aug; 375(5):403-5. PubMed ID: 27518657
    [No Abstract]   [Full Text] [Related]  

  • 8. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).
    McKay WF; Peckham SM; Badura JM
    Int Orthop; 2007 Dec; 31(6):729-34. PubMed ID: 17639384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.
    Simmonds MC; Brown JV; Heirs MK; Higgins JP; Mannion RJ; Rodgers MA; Stewart LA
    Ann Intern Med; 2013 Jun; 158(12):877-89. PubMed ID: 23778905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra. Bone morphogenetic protein 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, recombinant human bone morphogenetic protein 2--Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2--Genetics Institute/Medtronic-Sofamor Danek/Integra.
    BioDrugs; 2002; 16(5):376-7. PubMed ID: 12408742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Is the Clinical Relevance of Radiographic Nonunion After Single-Level Lumbar Interbody Arthrodesis in Degenerative Disc Disease?: A Meta-Analysis of the YODA Project Database.
    Noshchenko A; Lindley EM; Burger EL; Cain CM; Patel VV
    Spine (Phila Pa 1976); 2016 Jan; 41(1):9-17. PubMed ID: 26274529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA approves release of Medtronic's revolutionary Stormer Balloon Catheter.
    J Cardiovasc Manag; 2002; 13(5):30. PubMed ID: 12412360
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review.
    Arciero V; Delos Santos S; Koshy L; Rahmadian A; Saluja R; Everest L; Parmar A; Chan KKW
    JAMA Netw Open; 2021 Feb; 4(2):e2033004. PubMed ID: 33570573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pros, cons, and costs of INFUSE in spinal surgery.
    Epstein NE
    Surg Neurol Int; 2011 Jan; 2():10. PubMed ID: 21297932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finance Committee actions ready health reform debate for House, Senate floors.
    Wash Memo Alan Guttmacher Inst; 1994 Jul; (10):1-2. PubMed ID: 12318807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the osteoinductivity of bioimplants containing recombinant human bone morphogenetic proteins 2 (Infuse) and 7 (OP-1).
    Barr T; McNamara AJ; Sándor GK; Clokie CM; Peel SA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):531-40. PubMed ID: 20188607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneurysm-related mortality rates in the US AneuRx clinical trial.
    Tavris DR; Liu CH; Gross TP; Greenfield LJ
    J Am Coll Surg; 2010 Nov; 211(5):646-51. PubMed ID: 21035045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA: Stop Using Medtronic's Heartware Ventricular Assist Device.
    Kuehn BM
    JAMA; 2021 Jul; 326(3):215. PubMed ID: 34283195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.